![Lori Rudolph-Owen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Rudolph-Owen
Director/Board Member at
Codagenix, Inc.
Profile
Lori Rudolph-Owen is currently the Director at Codagenix, Inc. She has previously worked as the VP-Portfolio Management, Research & Development at Tesaro, Inc., the Chief Development Officer at Goldfinch Bio, Inc., and the Chief Operating Officer at Senda Biosciences, Inc. Dr. Rudolph-Owen holds a doctorate degree from Vanderbilt University.
Lori Rudolph-Owen active positions
| Companies | Position | Start |
|---|---|---|
Codagenix, Inc.
 Codagenix, Inc. Medical/Nursing ServicesHealth Services Provides platform technology to construct viral vaccines against multiple targets. | Director/Board Member | 2021-10-05 |
Former positions of Lori Rudolph-Owen
| Companies | Position | End |
|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Chief Operating Officer | - |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Corporate Officer/Principal | - |
| TESARO INC | Corporate Officer/Principal | - |
Training of Lori Rudolph-Owen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Provides platform technology to construct viral vaccines against multiple targets. | Health Services |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
- Stock Market
- Insiders
- Lori Rudolph-Owen
